Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Cancer Drug Targets | journal | 2.329 Q1 | 103 | 75 | 194 | 9712 | 1095 | 185 | 5.45 | 129.49 | |
2 | Current Gene Therapy | journal | 1.983 Q1 | 80 | 44 | 129 | 5188 | 719 | 126 | 5.86 | 117.91 | |
3 | Current Drug Targets | journal | 1.775 Q1 | 119 | 131 | 427 | 12582 | 1765 | 379 | 3.86 | 96.05 | |
4 | Current Medicinal Chemistry | journal | 1.758 Q1 | 202 | 282 | 767 | 43990 | 4314 | 766 | 5.35 | 155.99 | |
5 | Current Organic Synthesis | journal | 1.650 Q1 | 55 | 22 | 62 | 2806 | 214 | 61 | 3.78 | 127.55 | |
6 | Current Protein and Peptide Science | journal | 1.600 Q1 | 96 | 55 | 139 | 5811 | 609 | 132 | 4.35 | 105.65 | |
7 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.424 Q2 | 108 | 93 | 182 | 9648 | 833 | 167 | 4.33 | 103.74 | |
8 | Current Diabetes Reviews | journal | 1.231 Q1 | 68 | 35 | 115 | 2847 | 392 | 111 | 3.09 | 81.34 | |
9 | Infectious Disorders - Drug Targets | journal | 1.170 Q2 | 61 | 53 | 96 | 5332 | 289 | 86 | 2.78 | 100.60 | |
10 | Mini-Reviews in Medicinal Chemistry | journal | 0.984 | 107 | 149 | 394 | 14757 | 1314 | 391 | 3.26 | 99.04 | |
11 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.954 Q2 | 52 | 27 | 72 | 2740 | 246 | 72 | 3.07 | 101.48 | |
12 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.724 Q3 | 45 | 31 | 89 | 2650 | 210 | 88 | 2.28 | 85.48 | |
13 | Current Nanoscience | journal | 0.664 Q2 | 52 | 73 | 125 | 3658 | 245 | 122 | 1.62 | 50.11 | |
14 | Current Bioinformatics | journal | 0.627 Q3 | 38 | 25 | 29 | 1996 | 44 | 29 | 1.52 | 79.84 | |
15 | Current Genomics | journal | 0.609 Q3 | 77 | 61 | 152 | 4811 | 200 | 151 | 1.23 | 78.87 | |
16 | Current Chemical Biology | journal | 0.502 Q3 | 26 | 29 | 25 | 3046 | 42 | 25 | 1.68 | 105.03 | |
17 | Current Molecular Pharmacology | journal | 0.438 Q3 | 49 | 27 | 23 | 3594 | 29 | 23 | 1.26 | 133.11 | |
18 | Current Computer-Aided Drug Design | journal | 0.428 Q3 | 32 | 21 | 82 | 2108 | 135 | 76 | 1.78 | 100.38 | |
19 | Letters in Organic Chemistry | journal | 0.390 Q3 | 33 | 160 | 469 | 4768 | 408 | 468 | 0.80 | 29.80 | |
20 | Current Pharmaceutical Analysis | journal | 0.382 Q3 | 27 | 36 | 87 | 3007 | 106 | 87 | 1.04 | 83.53 | |
21 | Recent Patents on Biotechnology | journal | 0.349 Q3 | 42 | 21 | 42 | 2039 | 62 | 42 | 1.48 | 97.10 | |
22 | Letters in Drug Design and Discovery | journal | 0.281 Q4 | 37 | 98 | 299 | 2524 | 221 | 299 | 0.82 | 25.76 | |
23 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.241 Q4 | 39 | 34 | 78 | 3498 | 51 | 78 | 0.66 | 102.88 | |
24 | Current Proteomics | journal | 0.228 Q4 | 27 | 26 | 63 | 2369 | 49 | 62 | 0.91 | 91.12 | |
25 | Drug Metabolism Letters | journal | 0.216 Q4 | 31 | 40 | 101 | 1169 | 70 | 99 | 0.69 | 29.23 | |
26 | Current Pharmacogenomics and Personalized Medicine | journal | 0.213 Q4 | 20 | 27 | 26 | 2321 | 16 | 26 | 0.62 | 85.96 | |
27 | Current Enzyme Inhibition | journal | 0.205 Q4 | 19 | 20 | 74 | 2319 | 44 | 74 | 0.69 | 115.95 | |
28 | Current Cancer Therapy Reviews | journal | 0.173 Q4 | 17 | 32 | 100 | 3033 | 29 | 96 | 0.22 | 94.78 | |
29 | Current Signal Transduction Therapy | journal | 0.168 Q4 | 22 | 22 | 47 | 2387 | 18 | 47 | 0.38 | 108.50 | |
30 | Current Aging Science | journal | 0.149 Q4 | 42 | 26 | 27 | 1897 | 21 | 26 | 0.78 | 72.96 | |
31 | Open Biomarkers Journal | journal | 7 | 3 | 0 | 71 | 0 | 0 | 0.00 | 23.67 | ||
32 | Open Biotechnology Journal | journal | 18 | 8 | 0 | 311 | 0 | 0 | 0.00 | 38.88 | ||
33 | Open Medicinal Chemistry Journal | journal | 23 | 1 | 0 | 23 | 0 | 0 | 0.00 | 23.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®